Anti-maximal Electroshock Test of Agomelatine in Mice

Guo-Hua Gong,Ming Bian,Shu-Yin Bao,Zhe-Shan Quan
2015-01-01
Latin american journal of pharmacy
Abstract:Agomelatine (ALT) is a potent MT1 and MT2 melatonin receptor agonist used for treating depressant. It was reported that ALT has anticonvulsant activity shown in PTZ-or pilocarpine-induced seizure models, but not in the maximal electroshock (MES) seizure models. In our previously study there was antidepressant agent can protect animals suffer from the anti-MES in a very short period, so in this work we evaluated the anti-MES activity of ALT in Kunming mice. Results exhibited that ALT can protect animals suffer from MES-induced seizure with the peak time of 4 min, and the ED50 of ALT was 19.02 mg/kg at the peak time. Cabamazepine (CBZ) and phenobarbital sodium (PBS) could decrease the dose of ALT for anti-MES.
What problem does this paper attempt to address?